Marshall Wace LLP Buys 37,870 Shares of Dolby Laboratories, Inc. (NYSE:DLB)

Marshall Wace LLP raised its holdings in shares of Dolby Laboratories, Inc. (NYSE:DLB - Free Report) by 50.8% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 112,426 shares of the electronics maker's stock after acquiring an additional 37,870 shares during the quarter. Marshall Wace LLP owned approximately 0.12% of Dolby Laboratories worth $8,780,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Fifth Third Bancorp grew its position in Dolby Laboratories by 82.7% in the fourth quarter. Fifth Third Bancorp now owns 360 shares of the electronics maker's stock valued at $28,000 after purchasing an additional 163 shares in the last quarter. Nisa Investment Advisors LLC grew its position in shares of Dolby Laboratories by 436.2% in the 4th quarter. Nisa Investment Advisors LLC now owns 370 shares of the electronics maker's stock valued at $29,000 after acquiring an additional 301 shares during the period. Mather Group LLC. grew its position in shares of Dolby Laboratories by 36.8% in the 4th quarter. Mather Group LLC. now owns 528 shares of the electronics maker's stock valued at $41,000 after acquiring an additional 142 shares during the period. Headlands Technologies LLC bought a new position in shares of Dolby Laboratories in the 4th quarter valued at about $57,000. Finally, GAMMA Investing LLC grew its position in shares of Dolby Laboratories by 207.5% in the 4th quarter. GAMMA Investing LLC now owns 778 shares of the electronics maker's stock valued at $61,000 after acquiring an additional 525 shares during the period. 58.56% of the stock is owned by institutional investors.

Analysts Set New Price Targets

DLB has been the subject of a number of analyst reports. StockNews.com downgraded shares of Dolby Laboratories from a "strong-buy" rating to a "buy" rating in a research report on Friday, January 31st. Rosenblatt Securities reaffirmed a "buy" rating and set a $100.00 target price on shares of Dolby Laboratories in a report on Thursday, January 30th. Finally, Barrington Research reaffirmed an "outperform" rating and set a $100.00 target price on shares of Dolby Laboratories in a report on Thursday, February 13th.

Dolby Laboratories Stock Performance

Shares of DLB stock traded up $0.21 during midday trading on Monday, hitting $75.96. 322,632 shares of the company were exchanged, compared to its average volume of 453,339. The firm has a market capitalization of $7.25 billion, a P/E ratio of 27.93 and a beta of 0.94. The firm's 50 day moving average price is $78.18 and its two-hundred day moving average price is $78.31. Dolby Laboratories, Inc. has a 52 week low of $66.35 and a 52 week high of $89.66.

Dolby Laboratories Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, February 19th. Shareholders of record on Tuesday, February 11th were paid a $0.33 dividend. This represents a $1.32 annualized dividend and a yield of 1.74%. The ex-dividend date of this dividend was Tuesday, February 11th. Dolby Laboratories's dividend payout ratio (DPR) is 48.53%.

Insiders Place Their Bets

In other Dolby Laboratories news, CAO Ryan Nicholson sold 7,000 shares of Dolby Laboratories stock in a transaction dated Wednesday, February 5th. The shares were sold at an average price of $84.07, for a total value of $588,490.00. Following the completion of the sale, the chief accounting officer now owns 29,758 shares in the company, valued at $2,501,755.06. The trade was a 19.04 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CMO Todd Pendleton sold 18,121 shares of Dolby Laboratories stock in a transaction dated Wednesday, February 19th. The stock was sold at an average price of $83.75, for a total transaction of $1,517,633.75. Following the completion of the sale, the chief marketing officer now owns 37,290 shares of the company's stock, valued at $3,123,037.50. This trade represents a 32.70 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 65,121 shares of company stock worth $5,501,324 in the last quarter. 38.39% of the stock is currently owned by corporate insiders.

Dolby Laboratories Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.